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Polycyclic aromatic hydrocarbons (PAHs) ubiquitously exist in the environment. 
Most of them are procarcinogenic that acquire carcinogenicity only after the 
metabolic activation by by cytochrome P450 1 enzymes. Cytochrome P450 1 
enzymes convert PAHs to epoxide intermediates, which are further converted to more 
reactive diol-epoxides with the aid of epoxide hydrolase. The diol-epoxides attack 
DNA and result in PAH-DNA adducts formation and so leading to subsequent cancer. 
Aryl hydrocarbon receptor (AhR), an upstream regulator of cytochrome P450 1 
enzymes, is a ligand-activated nuclear transcription factor that mediates responses to 
PAHs. Upon the binding of the ligands, AhR is translocated to the xenobiotic 
responsive element and activates the gene expressions. As AhR plays a central role in 
the carcinogenesis of PAHs, development of AhR antagonists may be useful in 
reducing PAH toxicity. 
It is widely reported that certain phytochemicals are AhR antagonists. In the 
present study, three flavonoids, naringenin，hesperetin and isoliquiritigenin were 
employed to investigate the mechanism by which the interaction between PAH and 
AhR was blocked by phytochemicals. 
Real-time PGR results showed that naringenin, hesperetin and isoliquiritigenin 
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could inhibit 7,12-dimethylbenz[a]anthracene (DMBA)-mediated cytochrome P450 1 
enzymes induction in a concentration-dependent maimer in human breast cancer cell 
line MCF-7. Transient transfection of xenobiotic responsive element showed that the 
three flavonoids could suppress the transcriptional activity of AhR. To examine how 
the three flavonoids modulate the transcriptional activity of AhR, RNA degradation 
assay, western blotting analysis and electrophoretic mobility shift assay (EMSA) were 
performed. RNA degradation assay results showed that the half-life of AhR RNA was 
not affected by the flavonoids and the RNA half-life was not extended by DMBA. 
Western blotting results showed that the modulation of AhR activity was not regulated 
by the activities of mitogen activated protein kinases (MAPKs). EMSA result 
inducated that the DNA binding affinity of AhR was impaired by the flavonoids. In 
conclusion, naringenin, hesperetin and isoliquiritigenin are likely modulating the 




























AhR Aryl hydrocarbon receptor 
ARNT Aryl hydrocarbon receptor nuclear translocator 
CYP or P450 Cytochrome P450 
DMBA 7,12-dimethybenz[a] anthracene 
DMSO Dimethyl sulfoxide 




INK c-Jun N-terminal kinase 
NAR Naringenin 
PAH Polycyclic aromatic hydrocarbon 
PAS Per-Amt-Sim 
PKC Protein kinase C 
TCDD 2,3,7,8-tetrachlorodibenzo-p-dioxin 
XRE Xenobiotics responsive element 
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CHAPTER 1 GENERAL INTRODUCTION 
Aryl hydrocarbon receptor is a ligand-activated transcription factor that mediates 
biological effects of polycyclic aromatic hydrocarbons. It belongs to the basic 
helix-loop-helix transcription factor family. Aryl hydrocarbon receptor and its binding 
partner, aryl hydrocarbon receptor nuclear translocator, are evolutionarily conserved 
as they share homology to Sim and Per proteins of Drosophila and they are the mouse 
ahr gene (Burbach et aL, 1992). Ahr gene is composed of 11 exons spanning more 
than 30kb of DNA. Exon 2 contains the sequences encoding for the helix-loop-helix 
domain; exons 3-9 contains the PAS domain sequences and the sequences for the 
ligand binding domain is in exons 7 and 8 (Schmidt et aL, 1993). For AhR protein, the 
basic helix-loop-helix motif is in the N-terminal. Two PAS domains support the 
specific secondary interactions for AhR-ARNT dimerization. The C-terminal region is 
glutamine-rich and is involved in recruiting co-activator for transactivation (Fukunaga 
etal., 1995). 
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1 mnsssanity asrkrrkpvq ktvkpipaeg iksnpskrhr drlnteldrl asllpfpqdv 
61 inkldklsvl rlsvsylrak sffdvalkss ptemggqdn craanfregl nlqegefllq 
121 alngfvlwt tdalvfyass tiqdylgfqq sdvihqsvye lihtedraef qrqlhwalnp 
181 sqctesgqgi eeatglpqtv vcynpdqipp ensplmercf icrlrclldn ssgflamnfq 
241 gklkylhgqk kkgkdgsilp pqlalfaiat plqppsilei rtknfifrtk hkldftpigc 
301 dakgrivlgy teaelctrgs gyqfihaadm lycaeshirm iktgesgmiv Mltknnrw 
361 twvqsnarll ykngrpdyii vtqrpltdee gtehlrkmt klpfmfttge avlyeatnpf 
421 paimdplplr tkngtsgkds attstlskds Inpssllaam mqqdesiyly passtsstap 
481 fennffhesm necmwqdnt apmgndtilk heqidqpqdv nsfagghpgl fqdsknsdly 
541 simknlgidf edirhmqnek ffrndfsgev dfrdidltde iltyvqdsls kspfipsdyq 
601 qqqslalnss cmvqehlhle qqqqhhqkqv wepqqqlcq kmkhmqvngm fenwnsnqfV 
661 pfiicpqqdpq qynvftdlhg isqefpykse mdsmpytqnf iscnqpvlpq hskcteldyp 
721 mgsfepspyp ttssledfVt clqlpenqkh glnpqsaiit pqtcyagavs myqcqpepqh 
781 thvgqmqynp vlpgqqafln kfqngvlnet ypaeliminn tqttthlqpl hhpsearpfp 
841 dltssgfl 
X 
Fig. 1.1 Amino acid sequence of aryl hydrocarbon receptor (obtained from NCBI, 
GenBank: AAH69390.1) 
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Fig. 1.2 Functional domains of aryl hydrocarbon receptor protein 
‘.M 
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PAH metabolism and cytochrome P450 1 enzymes 
Polycyclic aromatic hydrocarbons (PAHs) are commonly found in our 
environment, and they can be isolated from diesel exhaust, barbequed meat, tobacco 
smoke, overheated cooking oil, etc (International Agency for Research on Cancer, 
1983; Environmental Protection Agency, 1990). Most of them are chemically inert 
and require metabolic activation by cytochrome P450 (CYP) enzymes to more 
reactive metabolites in order to exhibit carcinogenicity in our body (Guengerich, 
1991). CYP Is convert PAHs into epoxide intermediates, which are further converted 
to more reactive diol-epoxides with the aid of epoxide hydrolase (Shimada and 
Fujii-Kuriyama, 2004; Androutsopoulos et al. 2009). 
CYPl family consists of three members: CYPlAl, CYP1A2 and CYPIBI. 
Basal CYPlAl expression is negligible. High levels of CYPlAl expression and 
enzyme activity are detectable following the induction by PAHs (Nebert et al. 2004). 
Polymorphism in CYPlAl is shown to be associated with an increased risk of lung 
cancer (Hung et al. 2003; Shi et al 2007). CYP1A2 gene is induced by PAHs in liver, 
gastrointestinal tract, nasal epithelium and brain. CYP1A2 activity has been suggested 
to be a susceptibility factor for the colorectal cancer (Lang et al 1994). CYP IB 1 is 
not only responsible for the bioactivation of PAHs, but also involved in the oxidative 
metabolism of estrogens, catalyzing the conversion of estrogens to genotoxic catechol 
17 
estorgens (Tsuchiya et al. 2005). Polymorphism in CYPIBI is shown to be associated 
with an increased risk of prostate, breast and endometrial cancers (Tanaka et al. 2002; 
Sasaki et al. 2003). The inhibition of CYPls is shown to be beneficial in the 
prevention of PAH-DNA adduct formation in vivo and in vitro (MacDonald et al. 
2001; Kleiner e k / . 2002). 
i乂-
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Figure 1.3 Biotransformation of proactive PAHs into their reactive metabolites, 
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Figure 1.4 Carcinogenesis of PAH-DNA adducts formed from the 
biotransformation of PAH 
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Transactivation of CYPl enzymes by aryl hydrocarbon receptor 
PAHs are not only substrates, but also inducers of CYPls (Spink et al. 2008). 
The three CYPls are regulated by aryl hydrocarbon receptor (AhR) that interacts with 
the cis-regulatory xenobiotic responsive element (XRE), in the promoters of CYPls to 
activate the transcription of the genes (Durrin et al. 1987; Sissung et al. 2006; Okino 
et al 2007; Nukaya and Bradfield, 2009). AhR is associated with Hsp90, 
co-chaperone p23 and immunophilin-like protein XAP2 in cytoplasm in the absence 
of a ligand (Meyer et al. 1998; Meyer and Perdew 1999). Once activated by a ligand, 
the conformation of AhR changes and it dissociates from the chaperon proteins. The 
activated AhR translocates into the nucleus where it dimerizes with AhR nuclear 
translocator (ARNT). The heterodimer recognizes and binds to xenobiotic responsive 
element (XRE) in the promoters of CYPls and initiates gene transcription (Chang and 
Puga 1998; Tian et al. 1999; Kronenberg et al 2000). 
Studies using AhR-null mutant mice have revealed that AhR plays a critical role in the 
toxic effects PAHs (Femandez-Salguero et al. 1996; Mimura et al. 1997; Shimizu et 
al. 2000). Moreover, constitutive activation of AhR could still cause tumorigenesis in 
mice even they were not exposed to xenobiotic ligands (Andersson et al. 2002). Based 
on these studies, inhibition of AhR activity could be useful for the treatment of 
AhR-mediated carcinogenesis (Kitamura and Kasai 2006). 
21 
Cvtosol 
© ^ ^ 
产y广 
/ / Bimerisation 
% R ] / _ 




Figure 1.5 Schematic diagram showing the transactivation of AhR. 
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Potential roles of phytochemicals on AhR activity 
Experimental and epidemiological data have revealed that certain 
phytochemicals are effective in preventing PAH-induced carcinogenesis. Some of 
them act as inhibitors of CYPl enzymes to impair the transformation of PAHs into 
carcinogenic diol-epoxides. Usually they antagonize AhR-mediated transcription of 
CYPl enzymes. Apart from inhibiting AhR activity directly, phytochemicals may 
exert their effects via modulating other signaling pathways. The phytochemicals may 
modulate protein phosphorylation in inhibiting the transactivation activity of AhR 
since XRE binding of AhR/Amt heterodimer could be abolished by the phosphatase 
treatment (Pongratz et al. 1991; Mahon and Gasiewicz 1995; Park et al. 2000; 
Mimura and Fujii-Kuriyama 2003). PKC, ERK and JNK are reported to be critical for 
AhR/Amt activation (Long et a/. 1998; Tan et al. 2004). Curcumin, a phytochemcial 
isolated from Curcuma longa, is reported to be able to inhibit the phosphorylation of 
AHR and ARNT (Nishiumi et al 2007). 
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The metabolism of the flavonoids 
The biological effects of bioflavonoids are intensively studied. Their bioactive 
forms in vivo and the mechanisms by which they contribute the effects are also 
reported. Naringenin exists in vivo in its conjugated form. After the cleavage of its 
glycosidic bond in the small intestine, naringenin is absorbed and excreted as 
glucuronides. The glucumide of naringenin is detected in plasma as well as in urine 
(Rechner et. al, 2002). After ingestion, hesperetin undergoes acyl cleavage and the 
products are further metabolized by P oxidation to benzoic acids and carbon dioxide 
(Honohan et. al, 1976). Isoliquiritigenin is excreted in bile as butein and aglycone 
conjugated forms (Brown and Griffiths, 1983). 
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Significant of this project 
Extensive studies have been carried out to study the inhibitory effects of 
phytochemicals on AhR activity. Some phytochemicals, such as resveratrol, inhibits 
CYPls expression by acting as AhR antagonist and protects the cells against DNA 
damage by induced benzo[a]pyrene (Revel et al, 2001). 
In the present study, we tried to mimic the PAH-mediated toxicity by using 
MCF-7 breast cancer cell model. We then investigated in the effects of certain 
phytochemicals including naringenin, hesperetin and isoliquiritigenin on CYPl 
enzymes and the regulation of AhR activity in response to DMBA. We also tried to 
investigate how phytochemicals regulate the AhR activity. Flavonoids are abundant in 




CHAPTER 2 MATERIALS AND METHODS 
Chemicals and materials 
Chemicals 
Naringenin was obtained from Sigma Chemicals. Hesperetin and isoliquiritigenin 
were obtained from Indofine Chemical Co., Inc. (Hillsborough, NJ, USA). They were 
dissolved in dimethylsulphoxide (DMSO), purchased from Sigma Chemicals (St 
Louis, MO, USA) at a concentration of 100 mM as the stock. All other chemicals, if 
not stated, were gifts or acquired from Sigma Chemicals. 
Plasmids 
XRE-pTA-luc has been prepared in our lab. Firefly luciferase reporter plasmid 
pTA-luc was purchased from Clontech (Mountain View, CA, USA). Renilla luciferase 
control plasmid pRL was purchased from Promega Crop (Madison, WI, USA). 
CYPIBI promoter plasmid is a gift from Professor Yokoi (Faculty of Pharmaceutical 
Sciences, Kanazawa University, Japan) 
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Mammalian cell culture 
Maintenance of cells 
The human breast cancer cell line MCF-7 was purchased from American lype Culture 
Collection, Rockville, MD. The cells were grown in RPMI (Invitrogen, Grand Island, 
NY, USA) supplemented with 10% v/v fetal bovine serum (Invitrogen Life 
Technology, Rockville, MD) and 50 units/ml Penicillin-Streptomycin (GibcoBRL, 
USA). Cells were incubated at 37°C in 5% carbon dioxide. Cells were routinely 
sub-cultured when reaching 80% confluence. 
Cell recovery from liquid nitrogen stock 
The cell stock taken out from liquid nitrogen was thawed immediately in a 37°C water 
bath. The cell stock was diluted with RPMI. The cell suspension was centrifuged and 
the supernatant then was discarded. The cell pellet was suspended in RPMI and then 
plated on a 100 mm plate and maintained at 37°C in a humidified atmosphere of 95% 
air and 5% carbon dioxide. Medium was changed the day after recovery. 
� 
27 
Reporter gene assay 
Transient transfection of MCF-7 cells 
MCF-7 cells were seeded at 1 x 10^ cells/well in 24-well plates. After 24 hours, the 
cells were transiently transfected with 0.2|xg of XRE-pTA-luc plasmid and 1.5ng of 
renilla luciferase control vector pRL (Promega, Madison, WI, USA) per well in 25|il 
transfection medium (phenol red-free RPMI-1640 medium without serum). The mix 
was then mixed with 3|il PLUS™ Reagent (Invitrogen, Carlsbad, CA，USA). The 
DNA-PLUS™ Reagent complex was then incubated at room temperature for 15 
minutes. 1[l\ LipofectAmine™ Reagent (Invitrogen) was diluted with 25|il 
transfection medium in another microfuge tube. After incubation, the DNA-PLUS™ 
rp* * 
Reagent complex was mixed with the diluted LipofectAmine Reagent and the 
mixture was further incubated at room temperature for 15 minutes. 50|j,l 
DNA-PLUA™-LipofectAmine™ Reagent complex was added into each well and was 
mixed gently with the transfection medium. After 16-hour incubation, the transfection 
medium was removed and the cells were treated with 2|iM DMBA and various 
concentrations of different phytochemicals for 24 hours. After treatment, the cells 
X 
were lysed and the promoter transcription activites were determined by using 
Dual-Luciferase Assay Kit (Promega Corp.). 
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Dual Luciferase Assay 
Dual luciferase assay was performed according to manufacturer's instruction 
(Promega Corp.). The treated cells were lysed with lOO i^l IX Passive Lysis Buffer 
(PLB) provided in the kit with vigorous shaking. Then the cell lysates were 
centrifUged at 13,000 rpm at 4°C for 5 minutes. lOjil clear cell lysates were mixed 
with 50)11 reaction buffer supplemented with firefly luciferase substrate. The firefly 
luciferase bioluminescence was measured by the FLUOstar Galaxy plate reader 
(BMG Labtechnologies GmBH, Offenburg, Germany). 50|al renilla luciferase reaction 
buffer was added directly to the cell lysates after the firefly luciferase 
bioluminescence was measured. The renilla luciferase bioluminescence was then 
measured. The XRE-driven transactivation activities were represented by firefly 
luciferase light units normalized with that of renilla luciferase. 
Isolation ofRNA using TRIzol® Reagent 
Total RNA was isolated from cells treated with DMBA and phytochemicals by 
Trizol® Reagent as instructed by the manufacturer (Invitrogen). Cells were washed 
with PBS twice and TRIzol® reagent was added to each well and the cells were lysed 
by gentle shaking for 5 minutes. The homogenous samples were then transferred to 
1.5-ml microfuge tubes and then chloroform was added. The samples were mixed by 
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vigorously shaking for 15 seconds and were allowed to stand at room temperature for 
5 minutes. The samples were then centrifuged at 13,000 rpm for 15 minutes at 4°C. 
Afterward, the upper aqueous layer was transferred to a new 1.5-ml microfuge tube 
containing isopropanol and mixed thoroughly with vigorous shaking. The samples 
incubated at -20�C overnight were centrifuged at 13,000 rpm for 15 minutes at 4°C. 
The supernatant was discarded and the white RNA pellet was washed with 75% 
ethanol. The RNA pellet was again collected by centrifugation and air-dried. 
Diethypyrocarbonate (DEPC)-treated water was added to dissolve the RNA pellet. 
The RNA concentration and purity were determined by absorbance at 260/280 nm. 
3|Lig of total RNA was used for the first strand cDNA synthesis with oligo-dT. The 
single strand cDNA was then used as the template in the reverse transcription 
polymerase chain reaction (RT-PCR) for cDNA synthesis. 
Semi-quantitative real-time PGR 
The relative expression levels of certain genes mRNA in the phytochemical-treated 
samples were quantified with real time PGR. Real-time PGR Taqman Universal 
X 
Master Mix Reagent kit (Applied Biosystems, Foster City, CA, USA) was used and 
the reactions were set up according to manufacturers' instruction. The sample signals 
were amplified and detected using the MJ Research's DNA Engine Opticon™ 3 
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System (Bio-Rad Laboratories, Hercules, CA, USA). GAPDH expressions obtained 
were used as a reference housekeeping gene to normalize the amount of total RNA 
amplified in each reaction. The PGR cycling conditions were 50�C for 2 minutes, 
95°C for 10 minutes and 45 cycles of 95°C for 15 seconds and 60°C for 1 minute. All 
samples were run in triplicate or more. Relative gene expression data was analyzed 
using the2-AACTmethod (Livak and Schmittgen, 2001). 
RNA degradation assay 
MCF-7 cells were maintained as described above. Cells were seeded at 6-well plates 
with phenol red free RPMI-1640 medium one day before treatment. After 24 hours 
incubation with 2 \iM DMBA and various concentrations of NAR，HES and ILN, the 
medium was removed and the cells were washed with PBS twice. 4|xM of 
actinomycin D was added to inhibit transcription. Total RNA of the samples was 
extracted as described above at different time points (t=0 hour, t=l hours, t=2 hours 
and t=4 hours). The RNA degradation was determined by the remaining RNA level 




MCF-7 cells were seeded in 60mm plates at a density of 5 x 10^ cells per well with 
phenol red-free RPMI-1640 medium. Then the cells were treated with 2iiM DMBA 
and various concentrations of phytochemicals for 24 hours. The cells were then 
washed with PBS twice and scraped off from the plate with RIPA lysis buffer (25mM 
Tris-HCl pH8.8, 50mM NaCl, 0.5% NP40, 0.5% Deoxycholate, 0.1% SDS). The cell 
lysates were then subjected to sonication on ice for 30 seconds with cell disrupter 
(Branson Ultrasonics Corp., Danbury, CT, USA). The suspensions were centrifuged at 
13,000 rpm at 4°C for 5 minutes and then the proteins in the supernatant were 
collected. Protein concentration was determined by Bicinchoninic Acid (BCA) Assay 
(Pierce Biotechnology, Inc., Rockford, IL, USA) with bovine serum albumin (BSA) 
as standard. 30 \ig homogenized proteins were separated by sodium 
dodecylsulpahte-polyacrylamide gel electrophoresis (SDS-PAGE) on 10% resolving 
gel and transblotted to Immobilon-P polyvinylidene diflupride (PVDF) membrane 
(Millipore Corp., Bedford, MA, USA) afterwards. The membranes were incubated 
with primary antibodies: anti-phospho ERK and anti-phospho JNK (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA，USA), anti-phospho p38 (Cell Signaling 
Technology, Danvers, MA, USA), anti-phospho PKC (alpha) (Cell Signaling 
technology, Danvers, MA, USA) and anti-p-actin (Sigma Chemicals) at 4°C 
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overnight and then probed with appropriate secondary antibodies conjugated with 
horseradish peroxidase (Zymed Laboratories, South San Francisco, CA, USA) at 
room temperature for 1 hour. The membranes then were washed thoroughly with IX 
TBST. The antigen-antibody complexes were detected using enhanced 
chemiluminescence (ECL) detection kit (Amersham Biosciences, Piscataway, NJ, 
USA) and were visualized by autoradiography. 
Nuclear protein extraction 
Cells were maintained and treated with testing compounds as described above. The 
nuclear proteins were extracted using Novagen's NucBuster™ Protein Extraction Kit 
(EMD Biosciences, Inc., San Diego, CA, USA) as manufacturers' instruction. Cells 
were washed with PBS, trypsinized and pelleted by centrifugation at 1,000 rpm for 5 
minutes. The cell pellets were resuspended in NucBuster™ Reagent 1 with vigorous 
vortex for 15 seconds. The homogeneous suspensions were put on ice for 5 minutes, 
vortexed for another 15 seconds and then put on ice again. The cell suspensions then 
were subjected to centrifugation at 13,000 rpm at 4°C for 5 minutes. The pellets 
obtained were resuspended in NucBuster™ Reagent 2 with lOOX protease inhibitor 
and lOOmM DTT. The suspensions were put on ice for 5 minutes, vortexed for 15 
seconds and then put on ice again. After centrifugation at 13,000 rpm at 4°C for 5 
33 
minutes, the nuclear proteins were obtained in the supernatant. 
Electrophorectic Mobility Shift Assay (EMSA) 
Complementary strands of oligonucleotides with XRE binding site was commercially 
synthesized, annealed and labeled at 3,end with digoxigenin (DIG) using DIG Gel 
Shift Kit (Roche Applied Science, Indianapolis, IL, USA). Labeled probe was diluted 
to a final concentration of 1.55fmol/|il. lOjig nuclear protein was mixed with 
DIG-labeled probe and the binding reaction was carried out at 37�C for 30 minutes. 
Poly-L-lysine was applied to increase the DNA binding affinity and poly-[dI/dC] was 
applied to act as a non-specific competitor. For supershift experiment, anti-AhR 
antibody (Abeam, Cambridge, U.K.) was used. The antibody was incubated with the 
binding reaction mixture at 3TC for 30 minutes. After the incubation, the 
DNA-protein complexes were resolved by 5% non-denaturing polyacrylamide gel 
electrophoresis and transblotted to a positively charged nylon membrane. The 
membranes were then UV cross-linked. The embranes were soaked in Blocking 
Buffer at room temperature overnight, probed with anti-DIG antibody for 1 hour at 
room temperature and then washed in Washing Buffer 3 times. The membranes were 
then equilibrated in Detection Buffer for 10 minutes at room temperature and the 
DNA-protein complexes were detected by autoradiography with CSPD® solution 
34 
added. 
EROD activities in intact cells 
The assay method was performed as previously described (Choline et al, 1999). 
MCF-7 cells were seeded in 96-well plates and were treated with 2\iM DMBA and 
various concentrations of phytochemicals. The cells then were washed twice with 
100^1 PBS. Ethoxyresomfin-O-deethylase (EROD) activities were carried out by 
adding 5|xM ethoxyresorufin (ER) in PBS with 1.5mM salicyclamide. The reaction 
was stopped with ice-cold methanol and the resorufm generated was measured by 
FLUOstar Galaxy microplate reader with an excitation of 544nm and emission of 
590nm. 
Statistical Analysis 
Prizm5 software package (GraphPad Software, Inc., San Diego, CA, USA) was 
utilized for statistical analysis. The results, whenever applicable, were analyzed by 
two-tailed Student's t-test to determine if significant differences (P<0.05) were 
observed. One Way ANOVA with Tukey's posthoc test was used for multi-group 
comparisons. The results were expressed as means 士 SEM. 
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Chapter 3 Two citrus bioflavonoids suppress 
DMBA-induced CYPl gene expression and activity via 
antagonizing AhR transactivation activity 
Introduction 
Not only do citrus fruits provide abundant amounts of vitamin C, but they also 
supply bioflavaonoids that may improve our health. Two of the major bioflavonoids in 
citrus fruits, naringenin and hesperetin, have been demonstrated to possess 
anti-proliferative activity (So et al” 1996) and anti-inflammatory function (Ivanov et 
al., 2008). They have also been described as anti-cancer agents. Animal studies have 
demonstrated naringenin and hesperetin are able to inhibit chemically induced 
carcinogenesis. Yang et al. (1997) have demonstrated that dietary hesperetin 
administered during the initiation or the post-initiation phase could effectively inhibit 
mouse bladder carcinogenesis induced with N-butyl-N(4-hydroxybutyl)nitrosamine 
(OH-BBN). Leonard! et al. (2010) have shown that the administration of naringenin 
X 
lowered the number of high multiplicity aberrant crypt foci (HMACF) by 51% and 
colonocyte proliferation by 32% in azoxymethane-injected rats. In another study, the 
hamster cheek pouch model was utilized. The pouches were treated with solutions of 
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flavonoids and DMBA. Naringenin significantly lowered the tumor number in the test 
group (Miller et aL, 2008). Administration of naringenin could also protect against 
N-methyl N-nitro-N-nitrosoguanidine (MNNG)-induced and S-NaCl-promoted 
gastric cancer through its antioxidant ability (Ekambaram et aL, 2008). Flavonoids are 
reported to be able to antagonize aryl hydrocarbon receptor, and naringenin and 
hesperetin have been shown to be cytochrome P450 1 enzyme inhibitors (Doostdar et 
al.，2000). 
In this study, we investigated the inhibitory mechanisms of naringenin and 
hesperetin on DMBA-induced AhR transactivation. Protein kinases have been 
demonstrated previously to be regulatory factors in AhR transactivation (Pongratz et. 
aL, 1991; Chen el. al” 1996). Our hypothesis of current study was that naringenin and 
hesperetin could inhibit CYPl gene expression through protein kinase deactivation. 
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Figure 3.1 The structures of (A) naringenin and (B) hesperetin 
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Results 
EROD activities in intact MCF-7 cells 
EROD activity is an indicative of CYPlAl/ lBl and the downstream of AhR 
transactivation. The activities of both CYPl enzymes have been implicated in 
PAH-induced carcinogenesis in recent researches (Chan et al” 2003). EROD activities 
in intact cells were measured after the cells were treated with 2[iM DMBA and 
various concentrations of naringenin and hesperetin for 24 hours. DMBA-induced 
EROD activities in cell cultures were decreased by the two flavanones in a 
dose-dependent manner. The I C 5 0 values for naringenin and hesperetin were found to 
be around 0.5|jM and 0.4pM respectively as shown in Figure 3.2. These results 
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Figure 3.2 DMBA-induced EROD activities in MCF-7 cells treated with (A) 
naringenin and (B) hesperetin. 
MCF-7 cells were plated in 96-well culture plates and treated with 2|j,M DMBA and 
various concentrations of naringenin and hesperetin. After 24-hour incubation, EROD 
activity was measured as described. The estimated I C 5 0 value for naringenin is 0.5|iM 
and 0.4|j,M for hesperetin. The values are means 土SEM, n=3. Means with different 
letters differ (P<0.05). 
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XRE-Luciferase gene reporter assay 
Since phytochemicals share similar structure with polycyclic aromatic 
hydrocarbons, Zhang et. al (2003) have suggested that phytochemicals act as either 
agonist or antagonist to AhR dependent on the presence of xenobiotic. Since the 
activated AhR binds to XRE element to initiate transcription, this transient transfection 
assay could reflect the receptor status. From the results as shown in Figure 3.3, DMBA 
could induce the luciferase activitiy by 2-4 folds, and the luciferase activity then was 
reduced in a dose-dependent manner when naringenin or hesperetin was co-treated in 
the cell cultures. This showed that the DMBA-induced XRE transactivation activity 
could be impaired by naringenin and hesperetin. The expression of downstream genes 
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Figure 3.3 The effects of (A) naringenin and (B) hesperetin on XRE-driven 
luciferase activities. 
MCF-7 cells were first transient transfected with XRE-luciferase reporter plasmids, 
and then treated with 2|j,M DMBA and various concentrations of naringenin and 
hesperetin. Values are means 土SEM，n=3. Means with different letters differ (P<0.05). 
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The influence of naringenin and hesperetin on CYPIBI promoter activity 
There are eight XREs in the promoter of human CYPIBI (Tsuchiya et al., 2003). 
To evaluate the effect of naringenin and hesperetin on CYPIBI promoter activity, 
MCF-7 cells were transfected with a CYPIBI promoter-driven reporter construct. 
Luciferase activity was subsequently measured to reveal the transcription control of 
CYPIBI expression. DMBA induced the CYPIBI promoter-driven luciferase activity 
by 3-8 folds. The administration of 0.1, 1 and lOjiM of naringenin or hesperetin 
inhibited the promoter activity in a dose-dependent manner. 
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tfcggcccja ggtpcagag tgagactcca fcctciaaaaa aatasiataaa tsaaaa!:aafi 
MttMMm gccateacp m鄉seafctfc ctttatcagg tegcaaalt gattgctggt ttcaatctct caagaagtca, 
gattctcttc aiaeicmct ttgtgttfcct ^t^mcgta ^Ecagtcatt ccagggtcag ctatgaggca cactccectg 
gcctccctca taagcaatfet aattgCMag ggteagcata ctatttcttc tctgctattc tcaoaattcs： caatutpa 
'2000 adicaaaaaca ata^tfciaai agttcttsea gstgattttfe ttttfettt忧 tfcgapciga gtctcactta aactctgctg 
ccc&qgct^ z aftgcigtgg- t ^ m m x t gctctetgca acctctgcct cccacgttca accaattctg ctgccttccc 
4840 CGCtgatccc cgaptapS;g gpttaeagg Egtfeaccac cacgtccggc tMcttttgt atttttagta gafcggggttt 
-1760 cgccatgttg gsesfgGtgg tctcgaacfc® etfaoeteaa gtgatccgcc cgcttaagcc tcccaaagtg ctgggattac 
ac ^ ^ a g c agccccsogt. gcittttttt ttttttaagg gaggcagpa agaaggcatt tgggcctctt 
-1600 ffltctgcaacc ttcttcqitg taaactiatg tgaagptet fgagtgggac ttggtggctt caagccctgg ctceacttct: 
-1520 tg&ttfgcsige g雜aeefcggg t taagi^^aacctctct gaaccctagt ttattcacct gtaaacaggt ^ M t m m 
acgrigar.tgc agagcgigtg (jagctcaisag tgcagagttg tccctggtga acetatcact tttacattta tccfcttgatg 
aagccag^ iac; aattcc't^cc tffttaacea gaMatcod acetcttccc tcgagttcfc ccttcccccc gcctegtgaa 
42tO (|tccttgttc tettsge^g& ettpaiate ctsfcgcatca aagggcgc^c caggcggggg aagccsccc?^  
個i2M cgaccgafcg cctdGfijfefeo ccttataaag gpagggcccG cttcgcgaco gcaagcgcgc ccaggaagac cacagagccg 
»112Q ccfgtgcgca cggaggqgc gatacgc^cc sgggdtcggc etgcfggtgg t照cesaagc ftocgcetcg ctggcctag^ 
aggc^cgacc g i g ^ e g e s^ticcgagggt ggfcggcggcc ggcacc<tea(| ^ caagggtg gtgg^ggccg gcaccccacc 
-S6G ！2tcdgcc:gcc gcctccg^|_^:caggtg<;c gtgagaagcg cg c^aggagc ggccgc^gc agcgcccagn gatatgactg 
^agco^actt tccagaagcg gcgpiSaa agcccagctc c^^^aaa iggpggcga cacgapaac ttcaAcccp 
-SOO ua明ttege c^gipgepgg 鄉attegcet cctcetgcca ctctcc^tcc cgctogggtc ccgcttogtt agcfeccecca 
-726 ggccccccca gtcgeceeag ettggctccc； cgccctgcgc ？：為如ggete catcgcagcq tgggcggccc cgcgcccacc 
»64Q agc0g9cggc gcoacctgp gtfgcctcfca： cfcgggaaat ctcagggcGa gctgcgcccc aggagccttt gtgt^ccca^ 
fcactgisfg ggccjcqfggg sgggffageg gctaccttta ggpttcctg atctcgccgc aagaactgga aaaaatfctad 
-480 catpcasag agcctcacfe gaggtfgcaa. tttgtttgeg ag絲eet如g ataaaattta aacaacraac caggggcgct 
gt^ aggcaaa. ccgct^ccae bacacltfg^t ttccggpaf caigctcaag ccgcggagag ^gaagggagg tcgtgcgctc 
g雜gcgggge gcgcteccaa gtcgagcpa. gcgfccgggg caggttgtac c g E ^ ^ t tct^gggacii ccgtfcgg r^c 
"240 tCiattgpg gtgptftga tfaagcgcgg ttaocj^aea atgsaiicgt gggcatjcticc gctcccatga aagcctgctg 
-ISO gl^ agiigctctr ga^fcoggcc ggtgi^cctg gscggpg效 cgggtcaaag cggcctggtg tg j^ggcgcge cccgcccccc 
40 gragfgcscg ccs&gccagf tf^cgctgcc ctoettctae ccagtcctta. aimcccggag gagcgggatg gcgcgctttg 
Figure 3.4 Human CYPIBI promoter from -2299 to 0. XREs were boxed 
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Figure 3.5 Human CYPIBI promoter activity under co-treatment of DMBA 
and (A) naringenin or (B) hesperetin. 
MCF-7 cells were seeded in 24-well plates and transfected with CYPIBI promoter 
plasmid and Renilla luciferase control plasmid. After 24-hour incubation, the cultures 
were co-treated with 2|xM DMBA and 0.1, 1 and 10|iM of naringenin or hesperetin. 
The promoter activity was induced by 2|j-M DMBA by 3-8 folds and reduced with the 
administration of naringenin or hesperetin. Values are means +SEM, n=3. Means with 
different letters differ (尸<0.05). 
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The influences of naringenin and hesperetin on gene expressions of CYPH 
Since naringenin and hesperetin were shown to repress the XRE transactivation 
activity, the gene expressions of CYPls were studied. The real-time PGR results as 
illustrated in Figure 3.6 showed that the DMBA-induced CYPls expressions were 
suppressed by naringenin and hesperetin in a dose-dependent manner. The gene 
expressions were significantly induced by 2|iM DMBA and inhibited with the 
addition of naringenin and hesperetin. CYPIBI expression appeared to be less 
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Figure 3.6 CYPlAl gene expression in MCF-7 cells treated with DMBA, (A) 
naringenin and (B) hesperetin. 
MCF-7 cells were plated in 6-well culture plates and treated with 2|xM DMBA and 
various concentrations of naringenin and hesperetin for 24 hours. Total RNA was then 
isolated and reverse transcribed to cDNA. The relative gene expression was 
determined by real-time PGR. Values are means 土SEM，n=3. Means with different 
letters differ (尸<0.05). 
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Figure 3.7 CYP1A2 gene expression in MCF-7 cells treated with DMBA, (A) 
naringenin and (B) hesperetin. 
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Figure 3.8 CYPIBI gene expression in MCF-7 cells treated with DMBA, (A) 
naringenin and (B) hesperetin. 
Values are means 土SEM，n=3. Means with different letters differ (P<0.05) 
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The influences of naringenin and hesperetin on the DNA binding ability of AhR 
The binding of AhR to XRE is critical for the induction of CYPl enzymes; we 
performed EMSA to examine the effect of naringenin and hesperetin on AhR-XRE 
binding. To identify the responsible binding protein, supershift experiments were 
performed with AhR antibody. As flavonoids could either act as agonist or antagonist, 
MCF-7 cells were treated with the flavonones with or without DMBA. 
From the results, the AhR-XRE binding was induced by DMBA and the binding 
was impaired by 10|iM of the flavonoids. Without the addition of DMBA, the 
AhR-XRE binding was induced at low concentration of naringenin or hesperetin and 
then reduced at higher concentration of the flavonoids. 
Since the recognition site of the AhR antibody located at the DNA-binding 
domain, the addition of AhR antibody diminished the intensity of the band. 
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Figure 3.9 EMSA of MCF-7 cells treated with 2jiM DMBA and various 
concentrations of naringenin for 24 hours. 
Lane 1. XRE probe + MCF-7 nuclear extract with DMBA + AhR 
antibody 
Lane 2. XRE probe + control MCF-7 nuclear extract (DMSO) 
Lane 3. XRE probe + MCF-7 nuclear extract with 2\iM DMBA 
Lane 4-6. XRE probe + MCF-7 nuclear extract with 2\M DMBA and 0.1, 1 and 
10|iM of naringenin respectively 
Lane 7-9 XRE probe + MCF-7 nuclear extract with 0.1, 1 and 10|xM of naringenin 
respectively 
Nuclear binding assay of AhR-XRE was carried out with nuclear extract obtained 
from MCF-7 cells treated with 2|aM DMBA and various concentrations of naringenin 
for 24 hours. 
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Figure 3.10 EMSA of MCF-7 cells treated with 2jiM DMBA and various 
concentrations of hesperetin for 24 hours. 
Lane 1. XRE probe + MCF-7 nuclear extract with DMBA + AhR 
antibody 
Lane 2. XRE probe + control MCF-7 nuclear extract (DMSO) 
Lane 3. XRE probe + MCF-7 nuclear extract with 2|^M DMBA 
Lane 4-6. XRE probe + MCF-7 nuclear extract with DMBA and 0.1, 1 and 
lOjiM of hesperetin respectively 
Lane 7-9 XRE probe + MCF-7 nuclear extract with 0.1, 1 and lOjaM of hesperetin 
respectively 
Nuclear binding assay of AhR-XRE was carried out with nuclear extract obtained 
from MCF-7 cells treated with 2|xM DMBA and various concentrations of hesperetin 
for 24 hours. 
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The effects of naringenin and hesperetin on the nuclear translocation of AhR 
Before AhR binds to XRE and initiates gene transcription, it has to undergo 
nuclear translocation with the ligand bound. In order to elucidate if naringenin and 
hesperetin blocked the nuclear translocation and hence impaired the DNA binding 
activity of AhR, changes in AhR protein in cytosolic and nuclear fractions were 
analyzed. MCF-7 cells were treated with 2|iM DMBA and co-treated with 0.1，1 and 
10|iM of naringenin and hesperetin for 24 hours. The cytosolic and nuclear proteins 
were extracted using Novagen's NucBuster™ Protein Extraction Kit. In samples 
treated with DMBA alone and those co-treated with low dose level (0.1 jiM) of 
naringenin or hesperetin, AhR in the cytosol decreased with an concurrent rise of the 
protein in the nuclear fraction. This illustrated a translocation of AhR from the cytosol 
into the nucleus. With increased levels of naringenin or hesperetin added, this AhR 
translocation was stopped. 
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Figure 3.11 Western blotting of AhR in (A) cytosol and (B) nucleus. 
54 
RNA degradation assay 
MCF-7 cells were treated with 2p,M DMBA and 10|j,M naringenin or hesperetin 
for 24 hours before the addition of actinomycin D. After actinomycin D was added, 
the cells were harvested after 1，2 and 4 hours. Since there was no new RNA 
transcription upon the addition of actinomycin D, the existing RNA decayed steadily. 
Figure 3.12 shows that the half-life of AhR mRNA was approximately 2 hours. The 
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Figure 3.12 The mRNA of AhR degraded along time with the addition of (A) 
DMSO, (B) DMBA, (C) naringenin and (D) hesperetin. 
The amount of AhR mRNA was standardized to 100% right after actinomycin D 
administration. The mRNA level gradually dropped since no new mRNA was 
transcribed to replenish the degraded mRNA. At t=2 hr, the mRNA dropped to 50% of 
the starting amount. Values are means 土SD，n=3 
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Discussion 
In this study, we demonstrated that CYPls enzyme activity was impaired by 
naringenin and hesperetin as shown in EROD assay and the mRNA expressions of 
CYPls induced by DMBA were suppressed by naringenin and hesperetin. Since XRE 
is one of the most important cis-regulators in cyplbl promoter (which contains eight 
XREs), the reduction of DMBA-induced cyplbl promoter activity by naringenin or 
hesperetin was related to the inhibition of the transcription enhancement of XRE. The 
XRE-Luc reporter assay results confirmed that the down-regulation of CYPls gene 
expressions was associated with XRE binding activity. 
t 
With the addition of DMBA, AhR is activated and then translocates into nucleus 
and binds to XRE to initiate the transcription of its downstream genes. Electrophoretic 
mobility shift assay demonstrated that less activated AhR bound to XRE after the 
treatment of naringenin or hesperetin. When naringenin or hesperetin was 
administrated solely, the binding was firstly induced with low concentration of the 
flavonoids and then reduced with higher concentration. This revealed that naringenin 
and hesperetin might be a weak AhR agonist. While naringenin and hesperetin might 
be a weak AhR agonist, they did not block the nuclear translocation of AhR at low 
dose level. At higher dose level, they might be competing with DMBA for AhR 
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i. 
binding. They blocked the nuclear influx of AhR and impaired the DNA binding of 
AhR. Former study has shown that RNA stability is a factor of expression controlled 
by flavonoids (Choi et al., 2006). To investigate if naringenin and hesperetin exert 
their regulation of AhR at RNA level, the half-life of AhR mRNA was determined. 
The degradation of AhR mRNA was not fastened nor delayed even 10|a,M of 
naringenin or hesperetin was added. It appeared that naringenin and hesperetin did not 
regulate AhR at this transcriptional pathway. 
In summary, we demonstrated that DMBA-induced CYPl enzymes expression 
and activity were reduced by naringenin and hesperetin. The mechanism of the 
inhibition was mediated through blockade of the nuclear translocation of AhR and so 
impairing the AhR-XRE binding and its downstream transactivation activity. 
X 
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Chapter 4 Modulation of AhR-mediated CYPl enzymes 
transcription by licorice flavonoid isoliquiritigenin. 
Introduction 
Gan-Cao, or licorice, is the sweet-tasting rhizome of a bean plant. It is commonly 
used in Western countries for culinary purposes while it is a popular Chinese herbal 
medicine. It has a wide range of pharmacological applications including 
anti-inflammatory activity, anticancer activity and hepatoprotective action. It 
suppresses LPS signaling pathway through inhibiting NF-kappaB transactivation 
(Furusawa et al., 2009). Licochalcone A from licorice reduces azoxymethane-induced 
tumor formation in C57BL/6 mice (Kim et al., 2010). Licorice water extract decreases 
the cadmium-induced liver toxicity in rats by inhibiting the translocation of Bad to the 
mitochondria (Lee et aL, 2007). Isoliquiritigenin is one of many chemicals isolated 
from licorice. Studies suggest that isoliquiritigenin may process anticancer activities, 
such as including inhibiting induction of ACF and colon carcinoma development (Baba 
X 
et al” 2002), inhibiting epidermal ODC and suppressed DMBA effects (Yamamoto et 
al； 1991), inducing cell death and promotion ofBax expression in B16 melanoma 4A5 
cells (Iwashita et al” 2000), anti-proliferative activity (Maggiolini et al” 2002; 
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Kanazawa et al” 2003), inducing apoptosis (Jung et al., 2006). 
In this study, we investigated the effect of isoliquiritigenin on AhR-mediated CYPl 
enzymes transcription. Our hypothesis was that isoliquiritigenin could antagonize AhR 
transactivation activity and hence suppressing CYPl gene expression and activity. 
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The influence of isoliquiritigenin on EROD activities in intact MCF-7 cells 
To evaluate the influence of isoliquiritigenin on CYPl enzymes activities, EROD 
assay was performed in intact MCF-7 cells. The culture was co-treated with 2|iM 
DMBA and various concentrations of isoliquiritigenin for 24 hours. Isoliquiritigenin 
reduced the DMBA-induced EROD activities in MCF-7 cells in a dose-dependent 
manner. Upon the addition of isoliquiritigenin, less resomfm was generated from 
ethoxyresorufm by CYPlAl/ lBl since isoliquiritigenin inhibited CYPlAl/ lBl 
enzymes. Without isoliquiritigenin, the DMBA-induced CYPlAl / lBl activity wasn't 
affected (100%). The higher concentration of isoliquiritigenin was added, the slower 
the rate of the resomfm generation. The I C 5 0 value was found to be around 0.6|xM as 
shown in Figure 4.2. The result suggested the isoliquiritigenin could modulate the 
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Figure 4.2 DMBA-induced EROD activities in MCF-7 cells treated with 
isoliquiritigenin 
MCF-7 cells were plated in 96-well culture plates and treated with IjiM DMBA 
and various concentrations of isoliquiritigenin. EROD activity was measured as 
described after 24-hour incubation. The estimated I C 5 0 value for isoliquiritigenin is 
0.6|iM. The values are means 土SEM, n=3. Means with different letters differ (P<0.05). 
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Inhibition of DMBA-induced CYPl family mRNA levels by isoliquiritigenin 
The gene expressions of CYPl family proteins were studied with real-time PGR. 
2iM DMBA induced CYPlAl’ CYP1A2 and CYPIBI mRNA expressions by 20-150 
folds as shown in Figure 4.3. The increases were abated in a concentration-dependent 
manner with isoliquiritigenin co-treatment. This result showed that isoliquiritigenin 
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Figure 4.3 (A) CYPlAl, (B) CYP1A2 and (C) CYPIBI gene expressions in 
MCF-7 cells treated with DMBA and isoliquiritigenin. 
MCF-7 cells were treated with 2|iM DMBA and various concentrations of 
isoliquiritigenin for 24 hours in 6-well plate. Total RNA was then isolated and reverse 
transcribed to cDNA as described. Real-time PGR was performed to determine the 
relative mRNA expressions. Values are means 土SEM，n=3. Means with different letters 
differ (P<0.05). 
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CYPIBI promoter-driven luciferase activity 
MCF-7 cells were transfected with CYPIBI promoter fiised to a luciferase reporter 
gene and luciferase activity was subsequently measured to index the regulation of 
CYPIBI transcription by isoliquiritigenin. CYPIBI promoter activity was induced by 
treating the culture with 2jaM DMBA for 24 hours. The co-treatment of isoliquiritigenin 
with DMBA showed an inhibitory effect. The induction by DMBA was almost totally 
abolished when lO^M of isoliquiritigenin was added. It revealed that isoliquiritigenin 
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Figure 4.4 The inhibition of isoliquiritigenin on DMBA-induced cyplbl 
promoter activity. 
The cyplbl promoter activity was induced by 3 folds with the administration of 
2[iM DMBA. Isoliquiritigenin reduced the promoter activity and so the luciferase 
activity in a dose-dependent manner when co-treated with DMBA. Values are means 
土SEM，n=3. Means with different letters differ (P<0.05). 
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Inhibition of XRE-mediated transcription by isoliquiritigenin 
XRE, which is the binding site of AhR, is abundant in the promoters of CYP J; there 
are eight XREs in cyplbl promoter. To illustrate the modulation of CYPl gene 
expression by isoliquiritigenin is AhR-mediated, XRE-luciferase reporter plasmid was 
transiently transfected into MCF-7 cells. 2|^M DMBA and various concentrations of 
isoliquiritigenin were added to the culture 6 hours after transfection. The cells were 
harvested and the luciferase activities were measured after 24-hour incubation. Figure 
4.5 showed that isoliquiritigenin could suppress DMBA-induced AhR transactivation 
in a dose-dependent manner. 
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Figure 4.5 The effect of isoliquiritigenin on DMBA-induced XRE-driven 
luciferase activity. 
MCF-7 cells were transiently transfected with a luciferase reporter gene containing 
XRE mdsipRL. Transfected cells were treated with 2|iM DMBA in the presence of 0.1, 
1 and lO i^M isoliquiritigenin for 24 hours. Values are means 土SEM，n=3. Means with 
different letters differ (P<0.05). 
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Electrophoretic mobility shift assay (EMSA) 
The AhR-XRE binding is important for the induction of CYPl enzymes; EMSA 
was performed to evaluate the effect of isoliquiritigenin on the binding. To verify the 
AhR-XRE binding, AhR antibody was added to perform the supershift experiment. The 
addition of AhR abolished the AhR-XRE binding. The AhR antibody might recognize 
the sequence within the DNA-binding domain of AhR, and hence diminish the intensity 
of the band. Apart from the co-treatment of DMBA and isoliquiritigenin, MCF-7 cells 
were treated with isoliquiritigenin solely to see would isoliquiritigenin agonize or 
antagonize AhR without the presence of DMBA. 
As shown in figure 4.6, DMBA induced the AhR-XRE binding. The binding was 
impaired when 10|iM isoliquiritigenin was co-administrated. With isoliquiritigenin 
added solely, the AhR-XRE binding was slightly induced at low concentration of 
isoliquiritigenin and then reduced at higher concentration of the flavonoid. 
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Figure 4.6 EMSA of MCF-7 cells treated 2]iM DMBA and various 
concentrations of isoliquiritigenin for 24 hours. 
Lane 1. XRE probe + MCF-7 nuclear extract with 2|iM DMBA + AhR antibody 
Lane 2. XRE probe + control MCF-7 nuclear extract (DMSO) 
Lane 3. XRE probe + MCF-7 nuclear extract with 2ixM DMBA 
Lane 4-6. XRE probe + MCF-7 nuclear extract with 2|iM DMBA and 0.1, 1 and 
lOjiM of isoliquiritigenin respectively 
Lane 7-9. XRE probe + MCF-7 nuclear extract with 0.1，1 and 10|xM of 
isoliquiritigenin respectively 
Nuclear binding assay of AhR-XRE was carried out with nuclear extract obtained 
from MCF-7 cells treated with 2|xM DMBA and various concentrations of 
isoliquiritigenin for 24 hours. 
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Isoliquiritiegnin blocked the nuclear translocation of AhR 
AhR exists in the cytosplasm and translocates into nucleus after activation. The 
nuclear translocation is an important regulatory mechanism of AhR activity. MCF-7 
cells were treated with 2\xM DMBA and co-treated with 0.1，1 and lO^M of 
isoliquiritigenin for 24 hours. The cytosolic and nuclear proteins were extracted and 
AhR protein level in the two fractions were analyzed by using Western blotting. From 
the results, AhR translocated into the nucleus when DMBA was added, but its 
translocation was blocked when isoliquiritigenin was added. 
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Figure 4.7 Western blotting analysis of AhR in cytosol and nucleus 
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RNA degradation assay 
The half-life of the AhR mRNA was determined to investigate if isoliquiritigenin 
modulate AhR in post-transcriptional level. MCF-7 cells were treated with 2jiM 
DMBA and 10|iM isoliquiritigenin for 24 hours. Actinomycin D was added to interfere 
the elongation of growing RNA chains to stop the new generation of RNA. The half-life 
was determined as the existing RNA degraded along the time point t=0 hr, t=l hr, t=2 hr 
and t=4 hr. In figure 4.8, the half-life of AhR mRNA was shown to be around 2 hours. 
The half-life of AhR mRNA was not altered by DMBA or isoliquiritigenin. 
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Figure 4.8 The half-life of AhR was determined under (A) DMSO, (B) DMBA 
and (C) isoliquiritigenin treatment. 
At t=0, the mRNA of AhR was normalized to 100%. Along the time point, the 
mRNA level declined as no new mRNA was generated to replenish the degraded 
mRNA. The mRNA dropped to 50% at t=2 hr; i.e. the half-life of the AhR mRNA. 
Values are means 土SD，11=3. 
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Disucssion 
In this study, we demonstrated that CYP Is enzyme activity could be inhibited by 
isoliquiritigenin as shown in EROD assay. Apart from the enzymes activity, the gene 
expressions of CYP Is induced by DMBA could also be suppressed by isoliquiritigenin 
as shown in real-time PGR results. The regulation of CYP IB 1 in transcriptional level by 
isoliquiritigenin was revealed as isoliquiritigenin reduced the DMBA-induced CYP IB 1 
promoter activity. The regulation was further elucidated to be acting through AhR 
binding. 
Previous studied demonstrated that isoliquiritgenin could help protect against 
tumorigenesis casued by DMBA (Cuendet et al” 2010). The chemopreventive property 
of isoliquiritigenin may attribute to its activity in regulating the DMBA-induced CYPl 
transcription, which is mainly mediated by AhR. EMSA in the current study 
demonstrated that isoliquiritigenin impaired the AhR-XRE binding and hence the 
AhR-mediated CYPl expression. Slight increase in the binding was observed when low 
concentration of isoliquiritigenin was administrated alone. Isoliquiritigenin might be a 
weak agonist of AhR. From the Western blotting analysis of AhR level in cytosolic 
and nuclear fractions, isoliquiritigenin blocked the nuclear translocation of AhR. It 
might be due to competition between DMBA and isoliquiritigenin for the AhR 
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binding or the interference of the dissociation of AhR from the chaperon proteins in 
the cytosol. Isoliquiritigenin did not regulate AhR at the post-transcriptional level as it 
did not alter the stability of AhR mRNA. This report demonstrated the inhibitory 
effects of isoliquiritigenin on AhR-mediated CYPl expression induced by DMBA in 
MCF-7 cells. The inhibition might be due to the reduction of AhR-XRE binding by 
isoliquiritigenin. 
While isoliquiritigenin is known to be an AhR antagonist, it exerts its anti-tumor 
activity through diverse mechanisms. Cuendet et. al (2006) have shown that 
isoliquiritigenin delayed DMBA-initiated tumor formation in Sprague-Dawley rats. In 
addition, the phytochemical increased antioxidant response element (ARE) activity in 
HepG2 human hepatoma cells. ARE is a cw-acting regulator of phase II detoxification 
and antioxidant genes. Isoliquiritigenin is also a quinine reductase inducer which 
converts quinones to hydroquinones, reduces oxidative cycling and so it may inhibit 
the tumor-initiation stage. This Jias been verified in another study showing an 
inhibitory action on tumor-promoting stage caused by 
7-bromomethylbenz[a]anthracene (BrMBA) in DMBA initiated mice (Yamamoto et. 
al” 1991). 
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Chapter 5 Protein kinase signaling pathways are not 
involved in the modulation of AhR transactivation activity 
by flavonoids 
Introduction 
Protein kinases modify up to 30% of all human proteins and regulate many 
cellular pathways. Mitogen-activated protein kinases (MAPKs), one of the most 
important protein kinases, are used in a wide variety of biological responses. MAPKs 
in vertebrates are categorized into three subfamilies; i.e. extracellular signal-regulated 
kinases (ERKs), Jun N-terminal kinases (JNKs) or stress-activated protein kinases 
(SAPKs) andp38 MAPKs (Torres, 2003). 
ERKl and ERK2 are widely expressed and are involved in functions including 
the regulation of meiosis, mitosis, and postmitotic functions in differentiated cells. 
Many different stimuli, including growth factors, transforming agents and carcinogens, 
activate the ERK pathway. In MAPK/ERK pathway, Ras is activated by growth 
X 
factors and then activates c-Raf, followed by mitogen-activated protein kinase kinase 
and then ERKl/2, which activates transcription factors, such as ELKl (Gille et al； 
1995) afterwards. 
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JNKs are important in controlling programmed cell death or apoptosis (Toumier 
et al., 2000). JNKs bind and pliosphorylate the DNA binding protein c-Jun and 
increase its transcriptional activity. c-Jun is a component of AP-1 transcription 
complex, which is a regulator of gene expression. 
There are different isomers of p38 kinases: a, p, j and 5. p38a kinase is the most 
well-characterized and is expressed in most cell types. p38 MAPKs regulate the 
expression of many cytokines. They are activated by inflammatory cytokines 
(Raingeaud et al” 1995) and have an important role in activation of immune response. 
Other than inflammatory cytokines, p38 MAPKs are also activated by other stimuli, 
for instance, hormones (Pomerance et al, 2000; Kim et al., 2004) and stresses (Aggeli 
etaL, 2001). ’ 
Protein kinase C (PKC) is another important family of protein kinases that is 
involved in transduction of signals for cell proliferation and differentiation. Its 
importance is impicated in carcinogenesis and tumor cell invasion. Upon activated by 
tumor promoters, such as phorbol ester, PKC phosphorylates potent activators of 
transcription, thereby leads to increased expression of oncogenes, promoting cancer 
X 
progression (Yamasaki et aL, 2009). 
Several studies have suggested that AhR is activated by phosphorylation prior to 
binding to XRE and DNA-binding is abolished by phosphatase treatment of AhR in 
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vitro. Pongratz et al (1991) have shown that AhR is activated by treating Hepa lclc7 
cells with dioxin. Potato acid phosphatase treatment may result in a 
concentration-dependent decrease in the formation of AhR-XRE complex. Besides, 
PKC is shown to be involved in the nuclear events that result in the binding of AhR to 
XRE. Chen et al (1996) treated HepG2 cells with PMA. The treatment enhanced the 
transcriptional activation of CYPlAl induced by TCDD. When the cells were 
pretreated with PKC inhibitors, TCDD-induced or the PMA-enhanced CYPlAl gene 
transcription was completely blocked. 
In this study, we examined if upstream signal transduction pathways involved in 
the DMBA-induced AhR transactivation activity. The phospho-protein kinases were 
immunoblotted to illustrate if the protein kinases were deactivated by the flavonoids. 
81 
Simulus growth factors, mitogens stress，inflammatory cytokinse 
N / \1/ N / 
MAPKKK Raf;Mos, Tpl2 MLK3，TAK，DLK MEKK1,4 
MLK3,ASK1 
y V N/ ^ 
MAPKK MEKl/2 MKK3/6 MKK4/7 
4 / N / 
MAPK Erkl/2 p38lMAPK JNK1,23 
V � / \ l Z 
Biological Growth, Inflammation, 
Response Differeutiation， Apoptosis, Growth, 
Development Differentiation 
Figure 5.1 A schematic diagram showing the protein kinase pathways 
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Results 
Inhibition of DMBA-induced AhR transactivation activity was not via ERK 
signaling pathway 
Yim et al. study (2004) revealed that the inhibition of ERK reduces AhR-DNA 
interaction. They treated HepalclV cells with the inhibitor of ERK upstream kinase 
MEK-1, resulting in reduction of TCDD-induced cyplal expression. They also 
showed that TCDD-induced expression of a XRE-driven reporter by the dominant 
negative form of ERK. 
In this work, the phospho-ERK was immunoblotted to investigate if ERK is 
activated by DMBA and if ERK is involved in DMBA-induced AhR activation. 
MCF-7 cells were DMBA and various concentrations of flavonoids for 24 hours. Total 
protein was extracted and used to perform Western blotting. From Figure 5.2, the 




DMSO _ M a.lpM IjUVI WpM 
撒R . ； . ^ ^ ,、-K'.>' ‘、.、-:...-:•、‘父缚级(44kDa) 
• 於 、 二 , ( 4 2 k D a ) 
— 丨 铺 遍 ” ( 4 2 啊 
2HMBMBA 
BMSO OJ.HM lOpM 
騰 聽 蒙 . 
IpMBMBA 
OMvSO OfLM (UmM t\m lOuM 
( — a ) 
：•.：：;;；••¥；<.•；：;：：'；；：.......从.......，..... .iM ittfflMfi III I i liiiaiii niiMfiliiyir • Vi i ii .MMftii'ii i n .raM.ft"丨搬 
X ‘ 
Figure 5.2 Western blot analysis of phospho-ERK after DMBA and flavonoids 
treatment 
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JNK was not involved in DMBA-induced AhR activation 
In Tan et al. study (2004), JNK was shown to be involved in TCDD-induced 
CYPlAl expression. TCDD induced both CYPlAl mRNA and protein in wild type 
MEFs while the induction was markedly reduced to almost basal levels in 
Jiikl(-/-)Jnk2(-/-) double-knockout fibroblasts. The lack of JNK caused CYPlAl 
reduction in these cells. 
Since JNK inhibitor SP600125 is an AhR ligand itself (Joiakim et al； 2003)，it 
could not be used to investigate the role of JNK in AhR regulation, phosphor-JNK 
level was used to be indicative of JNK activation status. From Figure 5.3, the JNK 
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Figure 5.3 Western blot analysis of phospho-JNK after DMBA and flavonoids 
treatment 
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p38 was not activated nor suppressed by DMBA and flavonoids 
Though overexpression of the p38 MAPK dominant negative form could not 
suppress the transactivation of CYPlAl report gene by TCDD, it was reported that 
p38 modified the NES of AhR at Ser68 (Ikuta et al.’ 2004). To illustrate if p38 play a 
role in the regulation of AhR, the activation status of p38 after treatment of DMBA 
and flavonoids was analyzed. 
MCF-7 cells were plated in 60min plates and treated with DMBA and various 
concentrations of flavonoids. Total protein was extracted after 24-hour incubation. 
30|ig of protein was subjected to Western blotting and phospho-p38 was probed. 
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Figure 5.4 Western blot analysis of phospho-p38 after DMBA and flavonoids 
treatment. 
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DMBA-induced AhR activity was not suppressed through PKC signaling 
pathway 
The mechanism by which PKC regulates AhR-mediated signal transduction is 
poorly understood. Long et al. (1998) demonstrated that a PKC-mediated 
phosphorylation event is required for AhR to function. In their study, P5A11 and 
HG40/6, derived from HeLa and HepG2 cells respectively, were simultaneously 
treated with TCDD and PMA. The treatment enhanced transactivation of 
XRE-reporter several-fold relative to cells treated with TCDD alone. The addition of 
PKC inhibitors abolished the reporter activity. It revealed PKC-mediated 
phosphorylation might be required in AhR signaling pathway. 
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Protein kinases are essential for cell proliferation and differentiation. They are 
also involved in many cellular responses upon stimuli. Polycyclic aromatic 
hydrocarbon (PAH), a ubiquitous environmental pollutant activating AhR, is shown to 
be activating protein kinase signaling pathways as well (Tan et al., 2002). When 
overexpressing dominant negative form of protein kinases, TCDD-induced CYPl 
enzymes expression was suppressed. On the other hand, many flavonoids were 
suggested to be able to modulate the protein kinase signal pathways. 
In this study, we tried to figure out if naringenin, hesperetin and isoliquiritigenin 
modulate DMBA-induced AhR activity through protein kinase pathways. From the 
Western blotting of the phospho-protein kinases, the activation status of the protein 
kinases was neither induced nor reduced by DMBA or the flavonoids. The modulation 
of DMBA-induced AhR activity by the flavonoids was not acting through protein 
kinase signal pathways. 
The discrepancies between the results obtained and other studies might be due to 
X 
the differences in cell types and inducers. TCDD was used in other studies. TCDD 
mimics estrogen in vivo and so may trigger protein kinase signaling pathways related 
to estrogen and while DMBA is a kind of PAH. 
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Chapter 6 Summary 
In the present study, we investigated the effects of naringenin, hesperetin and 
isoliquiritigenin on DMBA-induced AhR transactivation activity in a human breast 
cancer cell line MCF-7. The results indicated that all the above phytochemicals were 
capable to suppress DMBA-induced CYPl enzymes expression and activity. Besides, 
the phytochemicals modulated the expression and activity through antagonizing AhR 
binding ability on XRE and hence its transactivation activity. 
I. Citrus and licorice flavonoids displayed inhibitory effects on 
CYPls induction by DMBA 
At the enzyme level, the three flavonoids showed inhibition on CYPl enzyme 
activity with I C 5 0 values ranging from 0.4|iM to O . 6 1 1 M in intact MCF-7 cells. 
At the gene transcription level, the three phytochemicals decreased CYPlAl, 
CYP1A2 and CYPIBI mRNA in a dose-dependent manner. They all completely 
abolished the induced mRNA expressions at lOjiM. 
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II. Flavonoids suppressed DMBA-mediated CYPls induction 
through blocking the nuclear translocation of AhR and 
antagonizing AhR transactivation activity 
The flavonoids prevented the induction of cyplbl- and XRE-driven luciferase 
activities by DMBA. The nuclear translocation of AhR was blocked by the flavonoids 
and the AhR-XRE binding was impaired by the flavonoids administration. 
III. The antagonism of DMBA-induced AhR activity was not 
modulated at the post-transcription or signal transduction 
levels 
The degradation of AhR mRNA was not affected by either DMBA or the 
flavonoids. The transcript stability was not involved in the modulation. Besides, 
DMBA and the flavonoids showed no effects on the phosphorylation status of protein 
kinases. , 
In summary, naringenin, hesperetin and isoliquiritigenin were all able to inhibit 
\ 
DMBA-induced CYPl expression and activity. They exhibited the effects through 
blocking the nuclear translocation of AhR and hence impairing the AhR-XRE binding 
and antagonizing AhR transactivation activity. 
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